全球糖尿病前期市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球糖尿病前期市場預計將從2025年的3.6377億美元成長至2034年的8.3899億美元，2026年至2034年的複合年成長率（CAGR）為9.73%。全球糖尿病前期市場預計將顯著成長，主要受糖尿病前期患病率上升以及人們對其健康影響的認知不斷提高的推動。糖尿病前期是指血糖值升高但尚未達到糖尿病診斷標準的階段，影響全球數百萬人口。隨著醫療專業人員和患者認知到早期療育對於預防發展為第2型糖尿病的重要性，對糖尿病前期篩檢、診斷工具和管理解決方案的需求預計將顯著成長，從而推動這一關鍵市場的創新和投資。

此外，數位健康技術和個人化醫療的進步預計將進​​一步擴大糖尿病前期市場。行動醫療應用程式、穿戴式裝置和遠距醫療平台的開發將使人們能夠監測血糖值、追蹤生活方式的改變，並獲得醫療專業人員的個人化指導。此外，人們越來越重視生活方式改善計劃，包括飲食改善和體能鍛煉，這推動了對綜合管理解決方案的需求，這些解決方案有助於人們掌控自己的健康。隨著醫療保健格局的不斷發展，糖尿病前期解決方案市場預計將迎來對滿足患者多樣化需求的創新產品和服務的激增。

此外，對監管合規和公共衛生措施的日益重視也將塑造糖尿病前期市場的未來。隨著各國政府和醫療機構實施旨在提高公眾意識和推廣預防措施的項目，對糖尿病前期篩檢和管理解決方案的需求預計將持續成長。醫療服務提供者、技術開發商和監管機構之間的合作對於推動這些進步至關重要，並確保糖尿病前期市場能夠繼續有效地滿足患者和醫療系統不斷變化的需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球糖尿病前期市場：依治療及管理方式分類

• 市場分析、洞察與預測
• 二甲雙胍
• 數位健康和​​穿戴設備
• 血糖監測設備（CGM、BGM）
• 草藥補充劑
• 其他（益生菌和腸道健康產品等）

第5章 全球糖尿病前期市場：依性別分類

• 市場分析、洞察與預測
• 男性
• 女士

第6章：全球糖尿病前期市場：依年齡層別分類

• 市場分析、洞察與預測
• 成人
• 兒童

第7章 全球糖尿病前期市場：依通路分類

• 市場分析、洞察與預測
• 線上
• 離線
• 專科藥房
• 藥局
• 超級市場
• 大賣場

第8章：全球糖尿病前期市場：依體重分類

• 市場分析、洞察與預測
• 超重人群
• 肥胖族群（主要目標族群）
• 體重正常但有代謝風險（漏診部分）

第9章 全球糖尿病前期市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診斷檢查室
• 居家醫療
• 專科診所
• 健康與健康中心

第10章 全球糖尿病前期市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • APHAIA PHARMA AG
  • Ascensia Diabetes Care
  • AstraZeneca PLC
  • Boston TherapeuticsInc
  • Bristol-Myers Squibb Company
  • Caelus Lifesciences
  • Danone SA
  • DexcomInc
  • Glenmark Pharmaceuticals Ltd
  • Herbalife Ltd
  • Medtronic Plc
  • Nestle Health Science
  • Novo Nordisk A/S
  • Pfizer Inc
  • Resverlogix Corp
  • Sandoz Group AG
  • Scimar Inc
  • Senseonics HoldingsInc
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Valbiotis
  • Viatris Inc.（Mylan Pharmaceuticals）

The global prediabetes market size is expected to reach USD 838.99 Million in 2034 from USD 363.77 Million in 2025, growing at a CAGR of 9.73 during 2026-2034.The global prediabetes market is poised for significant growth, driven by the increasing prevalence of prediabetes and the rising awareness of its health implications. Prediabetes, characterized by elevated blood sugar levels that are not yet high enough to be classified as diabetes, affects millions of individuals worldwide. As healthcare providers and patients recognize the importance of early intervention to prevent the progression to type 2 diabetes, the demand for screening, diagnostic tools, and management solutions for prediabetes is expected to rise substantially, fostering innovation and investment in this critical market.

Moreover, advancements in digital health technologies and personalized medicine are anticipated to further boost the prediabetes market. The development of mobile health applications, wearable devices, and telehealth platforms enables individuals to monitor their blood sugar levels, track lifestyle changes, and receive personalized guidance from healthcare professionals. Additionally, the growing emphasis on lifestyle modification programs, including dietary changes and physical activity, is driving the demand for comprehensive management solutions that empower individuals to take control of their health. As the healthcare landscape continues to evolve, the market for prediabetes solutions is likely to witness a surge in demand for innovative products and services that cater to diverse patient needs.

In addition, the increasing focus on regulatory compliance and public health initiatives is expected to shape the future of the prediabetes market. As governments and health organizations implement programs aimed at raising awareness and promoting preventive measures, the demand for prediabetes screening and management solutions will continue to rise. Collaborative efforts between healthcare providers, technology developers, and regulatory bodies will be essential in driving these advancements, ensuring that the prediabetes market remains responsive to the evolving needs of patients and healthcare systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Treatment & Management

• Metformin
• Digital Health and Wearables
• Glucose Monitoring Devices (CGM, BGM)
• Herbal Supplements
• Others (Probiotics and Gut Health Products, etc.)

By Gender

• Male
• Female

By Age Group

• Adult
• Pediatric

By Distribution Channel

• Online
• Offline
• Specialty Pharmacies
• Drugstores
• Supermarkets
• Hypermarkets

By Weight Category

• Overweight Individuals
• Obese Individuals (Primary Target)
• Normal Weight with Metabolic Risk (Underdiagnosed Segment)

By End User

• Hospitals
• Diagnostic Laboratories
• Home Care Settings
• Specialty Clinics
• Health and Wellness Centers

COMPANIES PROFILED

• Abbott Laboratories, APHAIA PHARMA AG, Ascensia Diabetes Care, AstraZeneca PLC, Boston Therapeutics, Inc., Bristol-Myers Squibb Company, Caelus Lifesciences, Danone S.A., Dexcom, Inc., Glenmark Pharmaceuticals Ltd., Herbalife Ltd., Medtronic plc, Nestle Health Science, Novo Nordisk A/S, Pfizer Inc., Resverlogix Corp., Sandoz Group AG, Scimar Inc., Senseonics Holdings, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Valbiotis, Viatris Inc. (Mylan Pharmaceuticals)

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PREDIABETES MARKET: BY TREATMENT & MANAGEMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Treatment & Management
• 4.2. Metformin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Digital Health and Wearables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Glucose Monitoring Devices (CGM, BGM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Herbal Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others (Probiotics and Gut Health Products, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PREDIABETES MARKET: BY GENDER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Gender
• 5.2. Male Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Female Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PREDIABETES MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age Group
• 6.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PREDIABETES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Drugstores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Supermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PREDIABETES MARKET: BY WEIGHT CATEGORY 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Weight Category
• 8.2. Overweight Individuals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Obese Individuals (Primary Target) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Normal Weight with Metabolic Risk (Underdiagnosed Segment) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PREDIABETES MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Health and Wellness Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PREDIABETES MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Treatment & Management
  • 10.2.2 By Gender
  • 10.2.3 By Age Group
  • 10.2.4 By Distribution Channel
  • 10.2.5 By Weight Category
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Treatment & Management
  • 10.3.2 By Gender
  • 10.3.3 By Age Group
  • 10.3.4 By Distribution Channel
  • 10.3.5 By Weight Category
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Treatment & Management
  • 10.4.2 By Gender
  • 10.4.3 By Age Group
  • 10.4.4 By Distribution Channel
  • 10.4.5 By Weight Category
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Treatment & Management
  • 10.5.2 By Gender
  • 10.5.3 By Age Group
  • 10.5.4 By Distribution Channel
  • 10.5.5 By Weight Category
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Treatment & Management
  • 10.6.2 By Gender
  • 10.6.3 By Age Group
  • 10.6.4 By Distribution Channel
  • 10.6.5 By Weight Category
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL PREDIABETES INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Abbott Laboratories
  • 12.2.2 APHAIA PHARMA AG
  • 12.2.3 Ascensia Diabetes Care
  • 12.2.4 AstraZeneca PLC
  • 12.2.5 Boston TherapeuticsInc
  • 12.2.6 Bristol-Myers Squibb Company
  • 12.2.7 Caelus Lifesciences
  • 12.2.8 Danone S.A
  • 12.2.9 DexcomInc
  • 12.2.10 Glenmark Pharmaceuticals Ltd
  • 12.2.11 Herbalife Ltd
  • 12.2.12 Medtronic Plc
  • 12.2.13 Nestle Health Science
  • 12.2.14 Novo Nordisk A/S
  • 12.2.15 Pfizer Inc
  • 12.2.16 Resverlogix Corp
  • 12.2.17 Sandoz Group AG
  • 12.2.18 Scimar Inc
  • 12.2.19 Senseonics HoldingsInc
  • 12.2.20 Sun Pharmaceutical Industries Ltd
  • 12.2.21 Teva Pharmaceutical Industries Ltd
  • 12.2.22 Valbiotis
  • 12.2.23 Viatris Inc. (Mylan Pharmaceuticals)